CINJ Experts Available for Comment on Risk Factors, Treatment Options and Latest Research
Newswise — New Brunswick, N.J., March 29, 2012 – While celebrity figures including Lance Armstrong, Scott Hamilton and Tom Green have brought their own brand of awareness to testicular cancer in recent years, cancer education advocates across the nation will also be shining a spotlight on this disease during Testicular Cancer Awareness Week (April 1 – 7). The Cancer Institute of New Jersey (CINJ) is making experts available to discuss various aspects of this disease, which, according to the National Cancer Institute, is the most common cancer among men between ages 20 and 34. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
The testicles are part of the male reproductive system and are responsible for making sperm and the male hormone testosterone. While testicular cancer is not common, its rate has been increasing in the U.S. and other countries, according to the American Cancer Society. In 2012, it is estimated that almost 8,600 men will develop testicular cancer in the U.S. and 360 will die of this disease. With the development of effective chemotherapy, often combined with surgery, the majority of men with testicular cancer will be cured. Those diagnosed with testicular cancer tend to be young Caucasian males, but the disease also can affect older males and even infants.
Risk factors for developing testicular cancer include:• Having an undescended testicle• Family history of testicular cancer• HIV infection• Cancer of the other testicle• History of pre-cancerous condition involving either one of the testicles
CINJ experts available for comment include:
Thomas L. Jang, MD, MPH, and Michael Karellas, MD, are both urologic oncologists at CINJ and assistant professors of surgery at UMDNJ-Robert Wood Johnson Medical School. Drs. Jang and Karellas are part of a comprehensive team that diagnoses and treats men with varied urologic cancers, including cancer of the testes. They can discuss the risk factors for developing testicular cancer, the latest treatment options available, advances in testicular cancer research and the benefits of a testicular self-exam. ###
RSS